As of Feb 16
| -0.18 / -5.54%|
The 1 analysts offering 12-month price forecasts for TapImmune Inc have a median target of 27.00, with a high estimate of 27.00 and a low estimate of 27.00. The median estimate represents a +779.48% increase from the last price of 3.07.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.